Published in J Hypertens on October 01, 2001
Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study (0954-133) | NCT00338260
Usefulness of electrocardiographic QT interval to predict left ventricular diastolic dysfunction. Am J Cardiol (2011) 1.02
Electrocardiographic changes with the onset of diabetes and the impact of aerobic exercise training in the Zucker Diabetic Fatty (ZDF) rat. Cardiovasc Diabetol (2010) 0.85
Electrocardiographic predictors of sudden cardiac death in patients with left ventricular hypertrophy. Ann Noninvasive Electrocardiol (2012) 0.85
Long QT syndrome in African-Americans. Ann Noninvasive Electrocardiol (2010) 0.84
Inter-relationship between electrocardiographic left ventricular hypertrophy and QT prolongation as predictors of increased risk of mortality in the general population. Circ Arrhythm Electrophysiol (2014) 0.83
B-Type Natriuretic Peptide Deletion Leads to Progressive Hypertension, Associated Organ Damage, and Reduced Survival: Novel Model for Human Hypertension. Hypertension (2015) 0.82
Signs of cardiac autonomic imbalance and proarrhythmic remodeling in FTO deficient mice. PLoS One (2014) 0.81
A novel electrocardiographic index for the diagnosis of diastolic dysfunction. PLoS One (2013) 0.79
A common variant near the KCNJ2 gene is associated with T-peak to T-end interval. Heart Rhythm (2012) 0.78
Coronary calcium score from multislice computed tomography correlates with QT dispersion and left ventricular wall thickness. Heart Vessels (2008) 0.78
The Relationship between Angiotensin-II Type 1 Receptor Gene Polymorphism and Repolarization Parameters after a First Anterior Acute Myocardial Infarction. Korean Circ J (2016) 0.75
Cardiac electrical activity in a genomically "humanized" chromogranin a monogenic mouse model with hyperadrenergic hypertension. J Cardiovasc Transl Res (2014) 0.75
Increased sarcolemmal Na(+)/H(+) exchange activity in hypertrophied myocytes from dogs with chronic atrioventricular block. Front Physiol (2013) 0.75
Digitized QT dispersion by the Valsalva maneuver in hypertensive patients. Korean J Intern Med (2005) 0.75
Interrelationship between electrocardiographic left ventricular hypertrophy, QT prolongation, and ischaemic stroke: the REasons for Geographic and Racial Differences in Stroke Study. Europace (2015) 0.75
Molecular determinants of repolarization time. Exp Clin Cardiol (2003) 0.75
Association Between ACE Gene Polymorphism and QT Dispersion in Patients with Acute Myocardial Infarction. Open Cardiovasc Med J (2016) 0.75
Diffuse interstitial fibrosis assessed by cardiac magnetic resonance is associated with dispersion of ventricular repolarization in patients with hypertrophic cardiomyopathy. J Arrhythm (2016) 0.75
Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol (1986) 18.40
Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation (1977) 9.70
Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet (1996) 7.84
Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med (2011) 7.62
Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet (1988) 7.59
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (2001) 7.47
Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol (1992) 6.51
Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med (1991) 6.08
Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol (1992) 4.65
Two-dimensional echocardiographic aortic root dimensions in normal children and adults. Am J Cardiol (1989) 4.27
The relationship between 'job strain,' workplace diastolic blood pressure, and left ventricular mass index. Results of a case-control study. JAMA (1990) 4.00
Association between dental health and acute myocardial infarction. BMJ (1989) 3.94
Rising tide of cardiovascular disease in American Indians. The Strong Heart Study. Circulation (1999) 3.82
Relation between QT intervals and heart rates from 40 to 120 beats/min in rest electrocardiograms of men and a simple method to adjust QT interval values. J Am Coll Cardiol (1994) 3.35
Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation (2001) 3.34
Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. Circulation (1987) 3.16
Life expectancy in the Marfan syndrome. Am J Cardiol (1995) 3.14
Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA (2001) 3.12
Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study. Circulation (1996) 3.07
Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement. J Am Coll Cardiol (1999) 2.98
Impaired chronotropic response to exercise stress testing as a predictor of mortality. JAMA (1999) 2.74
Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med (1999) 2.74
Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol (1995) 2.74
Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation (1993) 2.70
Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol (1984) 2.64
The heart in hypertension. N Engl J Med (1992) 2.53
Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria. J Am Coll Cardiol (1985) 2.50
Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point. Blood Press (1992) 2.49
All-cause mortality and cardiovascular disease mortality in three American Indian populations, aged 45-74 years, 1984-1988. The Strong Heart Study. Am J Epidemiol (1998) 2.43
Prognostic implications of left ventricular hypertrophy. Am Heart J (2001) 2.42
Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med (1986) 2.36
Relations of left ventricular mass to fat-free and adipose body mass: the strong heart study. The Strong Heart Study Investigators. Circulation (1998) 2.14
Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study. Circulation (2000) 2.10
Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur J Clin Invest (1999) 2.06
Mitral valve prolapse. Circulation (1976) 2.05
Prevalence and prognostic significance of short QT interval in a middle-aged Finnish population. Circulation (2007) 1.98
Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product. J Am Coll Cardiol (1992) 1.98
Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization, and comparison to other methods. Hypertension (1987) 1.97
Genetic linkage of the Marfan syndrome, ectopia lentis, and congenital contractural arachnodactyly to the fibrillin genes on chromosomes 15 and 5. The International Marfan Syndrome Collaborative Study. N Engl J Med (1992) 1.95
Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol (1995) 1.90
Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J (2002) 1.83
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation (1999) 1.82
Association of aortic dilation with regurgitant, stenotic and functionally normal bicuspid aortic valves. J Am Coll Cardiol (1992) 1.78
Lone atrial fibrillation in vigorously exercising middle aged men: case-control study. BMJ (1998) 1.77
Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance. Circulation (1998) 1.77
Severity of coronary artery disease in black and white male veterans and likelihood of revascularization. Am Heart J (2000) 1.76
Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation (1990) 1.72
Mitral valve prolapse in the general population. 1. Epidemiologic features: the Framingham Study. Am Heart J (1983) 1.72
Heart rate variability and progression of coronary atherosclerosis. Arterioscler Thromb Vasc Biol (1999) 1.70
Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study. Circulation (2001) 1.69
Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol (1999) 1.68
Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol (1994) 1.67
Decreases by magnesium of QT dispersion and ventricular arrhythmias in patients with acute myocardial infarction. Eur Heart J (1999) 1.67
Stroke volume and cardiac output in normotensive children and adults. Assessment of relations with body size and impact of overweight. Circulation (1997) 1.64
Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension (1994) 1.63
Impact of arterial stiffening on left ventricular structure. Hypertension (2000) 1.62
AT1-receptor blockers in hypertension and heart failure: clinical experience and future directions. Eur Heart J (1999) 1.61
Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. Circulation (1983) 1.60
Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects. J Am Coll Cardiol (1999) 1.59
Inheritance of mitral valve prolapse: effect of age and sex on gene expression. Ann Intern Med (1982) 1.58
LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study. Arterioscler Thromb Vasc Biol (2000) 1.56
The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol (1986) 1.56
Telomere length and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. J Hum Hypertens (2011) 1.56
The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. J Am Coll Cardiol (2001) 1.55
Prognostic significance of the pattern of aortic root dilation in the Marfan syndrome. J Am Coll Cardiol (1993) 1.54
Initial clinical experience with ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor blocker with ISA--a multicentre trial in 59 patients. Br J Clin Pharmacol (1984) 1.53
Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism (1992) 1.52
Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trial. Lancet (2001) 1.52
Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment. Am Heart J (1995) 1.51
Parallel cardiac and vascular adaptation in hypertension. Circulation (1992) 1.51
Are left ventricular mass, geometry and function related to vascular changes and/or insulin resistance in long-standing hypertension? ICARUS: a LIFE substudy. J Hum Hypertens (2003) 1.51
Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators. J Hypertens (2001) 1.49
Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension. N Engl J Med (1995) 1.47
Effect of electroconvulsive therapy on the electrocardiogram and echocardiogram. Anesth Analg (1992) 1.47
Electrocardiographic detection of left ventricular hypertrophy using echocardiographic determination of left ventricular mass as the reference standard. Comparison of standard criteria, computer diagnosis and physician interpretation. J Am Coll Cardiol (1984) 1.46
A 5-year prospective, observational study of the withdrawal of antihypertensive treatment in elderly people. J Intern Med (1994) 1.46
Repolarization abnormalities detected by magnetocardiography in patients with dilated cardiomyopathy and ventricular arrhythmias. J Cardiovasc Electrophysiol (2001) 1.45
Early combination therapy with telmisartan plus amlodipine for rapid achievement of blood pressure goals. Int J Clin Pract (2013) 1.44
Consistency of blood pressure and impact on cardiovascular structure over 20 years in young men. J Intern Med (2009) 1.43
Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults. J Am Coll Cardiol (1996) 1.43
Early changes in plasma and urinary potassium in diuretic-treated patients with systemic hypertension. Am J Cardiol (1984) 1.43
What is the role of ambulatory blood pressure monitoring in the management of hypertensive patients? Hypertension (1985) 1.42
Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings. Circulation (1981) 1.42
Rapid monitoring of regional myocardial ischaemia with echocardiography and ST segment shifts in man. Modification of "infarct size" and hemodynamics by dopamine and beta blockade. Acta Med Scand Suppl (1978) 1.41